FDA approves most expensive drug ever, a $3.5 million-per-dose gene therapy for hemophilia B
The single-dose medicine "represents important progress" as the first-ever gene therapy for the rare disorder, the FDA said. ”The Food and Drug Administration cleared Hemgenix, an IV treatment for adults with hemophilia B, the less common form of the genetic disorder which primarily affects men.”
Source: cbsnews.com
Databunker secure storage
Really like this approach putting privacy tools all in one place. Warrants some experimentation. "Databunker gives strong, serious, real personal-data protection for customer records without expensive custom coding and with full customer visibility."
Source: databunker.org
Dreadful user experience can be expensive.
"Citibank just got a $500 million lesson in the importance of UI design: Citibank was trying to make $7.8M in interest payments. It sent $900M instead." The screenshot is from court records where the judge ruled against Citibank who had wanted to get their money back. The lesson is to always include...
Source: arstechnica.com
My next Tweet could be generated by a deep-learning neural network.
My next tweet could be generated by a deep-learning neural network. I've been training one. Would anyone notice the difference? Could I just hand over tweeting to my machine? Method: downloaded the last 3200 Tweets that I posted using allmytweets.netpruned the dates off and removed the RTs by using some...
Source: agnate.co.uk
The 3 Reasons the U.S. Health-Care System Is the Worst: The head of the Commonwealth Fund, which compares the health systems
The 3 Reasons the U.S. Health-Care System Is the Worst: The head of the Commonwealth Fund, which compares the health systems of developed nations, pinpoints why American health care is so expensive and inefficient.
Source: theatlantic.com
Is pharma rolling in cash or on the brink of a long-term decline? - Healthcare Economist "Although successful drugs often
Is pharma rolling in cash or on the brink of a long-term decline? - Healthcare Economist "Although successful drugs often are expensive, most drugs fail. Thus, while the returns from a blockbuster drug are large, returns from a companies’ entire portfolio may be very modest. Additionally, finding...
Source: healthcare-economist.com
Day 1408 - #thecrapartist - Garden steps and foliage. Supportive advice from the pro artist was to use a sponge to build
Day 1408 - #thecrapartist - Garden steps and foliage. Supportive advice from the pro artist was to use a sponge to build up foliage. Will now have to invest in a sponge - an expensive watercolour sponge of course.
Human Insulin for Type 2 Diabetes: An Effective, Less-Expensive Option: This Viewpoint suggests that clinicians prescribe
Human Insulin for Type 2 Diabetes: An Effective, Less-Expensive Option: This Viewpoint suggests that clinicians prescribe human insulin products as a more-affordable option over insulin analogues and explains dosing options. Kasia J. Lipska. Irl B. Hirsch. Matthew C. Riddle. JAMA.
Source: jamanetwork.com
Fake Malaria Meds Meet Their Match in a Handheld Spectrometer: Up to 35 percent of antimalarial drugs are useless. Engineers
Fake Malaria Meds Meet Their Match in a Handheld Spectrometer: Up to 35 percent of antimalarial drugs are useless. Engineers are combatting this counterfeit menace. "The new system uses near-infrared (NIR) spectrometry, directing a beam
of NIR light at a pill and recording how the light is absorbed....
Source: ieee.org
Cancer Drug Fund didn’t deliver value ‘to patients or society’: A fund that spent more than £1 billion on expensive
Cancer Drug Fund didn’t deliver value ‘to patients or society’: A fund that spent more than £1 billion on expensive new cancer drugs in England had little clinical benefit, a study of 29 medicines has concluded
Source: newscientist.com
Remote intelligence will be with us before artificial intelligence concludes Richard Baldwin in his book "The Great Convergence".
Remote intelligence will be with us before artificial intelligence concludes Richard Baldwin in his book "The Great Convergence". He proposes this future by explaining the present state of global trade in terms of three "separation costs"; transport, knowledge, and people. Transport costs fell with...
Source: amazon.co.uk
Good read. Animal Liberation by Peter Singer. A powerful book on animal rights written 40 years ago (updated 20 years ago
Good read. Animal Liberation by Peter Singer. A powerful book on animal rights written 40 years ago (updated 20 years ago and re-issued recently with an introduction by Yuval Hariri) and having stood the test of time and debate. It is called 'the bible' of the animal rights movement and rightly so ......
Source: amazon.co.uk
FDA Approves Less Expensive Insulin Glargine: By Kristin J. Kelley Edited by André Sofair, MD, MPH, and William E. Chavey,
FDA Approves Less Expensive Insulin Glargine: By Kristin J. Kelley
Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS
The FDA has approved an insulin glargine injection (marketed as Basaglar) for treating type 1 (adult and pediatric patients) and … NEJM Journal Watch.
Source: jwatch.org
3-D printing provides low-cost alternative in bronchoscopy simulation training: Researchers from Beth Israel Deaconess Medical
3-D printing provides low-cost alternative in bronchoscopy simulation training: Researchers from Beth Israel Deaconess Medical Center in Boston, Massachusetts, found that 3D-printed tracheobronchial tree models compared favorably against other more standard models in training pulmonary physicians to...
Source: medicalxpress.com
U.S. cancer doctors drop pricey drugs with little or no effect: U.S. oncologists, aware that patients are paying more of
U.S. cancer doctors drop pricey drugs with little or no effect: U.S. oncologists, aware that patients are paying more of the costs of expensive cancer drugs, are increasingly declining to prescribe medicines that have scant or no effect, even as a last resort.
Source: reuters.com
Call for Britain to over-ride patents on Roche cancer drug: A group of patients and campaigners has called on Britain's
Call for Britain to over-ride patents on Roche cancer drug: A group of patients and campaigners has called on Britain's health minister to over-ride patents protecting Roche's expensive breast cancer drug Kadcyla to allow for the import or manufacture of cut-price copies.
Source: reuters.com
RSS feed